Share Twitter LinkedIn Facebook Email Howard Hochster, MD, explains the outcomes of the ECOG-7208 study in 2nd line metastatic colorectal cancer (mCRC) patients at Annual Meeting 2018.
NATERA GALAXY Study Links ctDNA Status to Survival & Treatment Response ESMO 2024 Colorectal 4 Mins Read
KRYSTAL-1: Adagrasib + Cetuximab Promise for KRASG12C Colorectal Cancer – Scott Kopetz, MD [AACR 2024] Colorectal 3 Mins Read
2024 Optimistic Advances in Colorectal Cancer: New Genetic Discoveries & Dancing Colorectal 5 Mins Read
